TNBC cancers, defined as tumors that lack ER, PR and HER2 expression, account for 12%–17% of all invasive breast carcinomas and comprise a heterogeneous group of tumors, with varying histological features and clinical behavior [112]. Here, ESR1 is linked to cancer.